home > Company Profile > Course of Growth
1943
In 1943, a Japanese businessman set up Fushou Grand Pharmaceutical Factory.
1948
Sino-Japanese War victory, the National Government took over, changed the Central Experimental Department of Biochemistry Pharmaceutical Factory Shanghai pharmaceutical experiments, the production of glucose, vitamin C, vitamin B1 and other injections.
1953
Change after the liberation of Shanghai No. 1 Pharmaceutical Factory.
1956
Successful trial production of whey acid (vitamin B13).
1958
Trial of vitamin B1 and sulfadiazine success and production, developed into a professional manufacturer of injection.
1963
Thiamine hydrochloride using imported raw materials and waste when the system injection, trial C Thiamine (TPD) and put into production.
1965
Thiamine nitrate into first by the advanced technology of thiamine hydrochloride, thiamine hydrochloride domestic production to fill the gap.
1966
Production of aminoglycoside antibiotics dihydrostreptomycin sulfate injection.
1969
Production of broad-spectrum aminoglycoside antibiotic Kanamycin sulfate injection, gentamicin sulfate injection.
1981
Production of anti-ulcer drug cimetidine injection digestive system.
1984
Production of non-morphine analgesics Naifu Pan injection.
1985
Production of cardiac β1 receptor stimulant dobutamine hydrochloride injection.
1990
Production of anti-ulcer drug metabolism enzyme inhibiting drug ranitidine injection.
1937
In August 1937, Mr. Yang Shuxun, who obtained his doctorate in Chemistry in USA, founded Yang Chemical Treatment Research Institute.
1944
Successfully developed the first bio-pharmaceutical treatment of diabetic islet Meng (ie, insulin), the titer of 16 units per mg.
1956
Yang Shanghai Biochemical Pharmaceutical Factory Pharmaceutical was renamed as Shanghai became China's first specialized biochemical laboratories.
1958
Developed extracted from the urine of pregnant women chorionic gonadotropin, to fill the gaps.
1959
Development of therapies for diseases of the stomach and duodenum membrane elements.
1960
Development of vitreous acid enzyme and oxytocin for the expansion of vascular kallikrein.
1968
Successfully developed the first synthetic internal peptide drugs increase blood pressure factor.
1969
Synthetic oxytocin peptide drug trial success.
1975
Production of coenzyme A, a domestic first the biosynthesis of biochemical products.
